LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,497
تعداد دریافت فایل اصل مقاله11,291,293
Aflaki, Elham, Farahangiz, Saman, Salehi, Alireza. (1399). Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire. سامانه مدیریت نشریات علمی, 45(5), 352-358. doi: 10.30476/ijms.2020.72634.0
Elham Aflaki; Saman Farahangiz; Alireza Salehi. "Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire". سامانه مدیریت نشریات علمی, 45, 5, 1399, 352-358. doi: 10.30476/ijms.2020.72634.0
Aflaki, Elham, Farahangiz, Saman, Salehi, Alireza. (1399). 'Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire', سامانه مدیریت نشریات علمی, 45(5), pp. 352-358. doi: 10.30476/ijms.2020.72634.0
Aflaki, Elham, Farahangiz, Saman, Salehi, Alireza. Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire. سامانه مدیریت نشریات علمی, 1399; 45(5): 352-358. doi: 10.30476/ijms.2020.72634.0

Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire

Iranian Journal of Medical Sciences
مقاله 5، دوره 45، شماره 5، آذر 2020، صفحه 352-358    اصل مقاله (239.19 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2020.72634.0
نویسندگان
Elham Aflaki1؛ Saman Farahangiz* 2؛ Alireza Salehi3
1Department of Rheumatology, Shiraz University of Medical Sciences, Shiraz, Iran
2Community Medicine Specialist, Department of MPH, Shiraz University of Medical Sciences, Shiraz, Iran
3Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Behçet’s disease (BD) can negatively impact the quality of life (QoL) of the affected patients. The present study aimed to assess the QoL of BD patients using the Leeds BD-QoL and compare its results with the WHOQOL-BREF questionnaire.
Methods: In the present cross-sectional study, 179 BD patients and 304 healthy individuals (the control group) were recruited in Shiraz, 2017. The Persian version of the Leeds BD-QoL and WHOQOL-BREF questionnaires were used to assess the QoL of patients with BD. The QoL in the patient and control groups was compared after controlling the effect of some variables (age, sex, marital status, and educational level) using the multiple linear regression analysis. Spearman’s correlation coefficient was calculated for the Leeds BD-QoL and WHOQOL-BREF scores. Disease activity was measured using the Behçet’s Disease Current Activity Form. All the statistical analysis was performed using SPSS software (version 21.0). p Results: The mean of the Leeds BD-QoL total score in the patient group was 12.3±8.7. The control group had significantly higher scores in the WHOQOL-BREF total score and the physical health and psychological health domains compared with the patient group; mean difference of 10.24, 10.8, and 4.62, respectively (p <0.001). The Spearman’s correlation coefficient for the Leeds BD-QoL score and WHOQOL-BREF total score and its domains (physical health, psychological health, social relationships, and environment) was -0.669, -0.713, -0.714, -0.536, and -0.550, respectively. The disease activity score was correlated with the Leeds BD-QoL score (r=0.361, p <0.001).
Conclusion: BD patients had a lower QoL than healthy individuals, specifically in the physical health and psychological health domains. An increase in disease activity and severity was associated with a reduced QoL. The Persian version of the Leeds BD-QoL questionnaire had an acceptable correlation with the WHOQOL-BREF questionnaire.
کلیدواژه‌ها
Behçet’s disease؛ Quality of life؛ Leeds BD-QoL
سایر فایل های مرتبط با مقاله
مراجع
  1. Kaneko F, Togashi A, Saito S, Sakuma H, Oyama N, Nakamura K, et al. Behcet’s disease (Adamantiades-Behcet’s disease). Clin Dev Immunol. 2011;2011:681956. doi: 10.1155/2011/681956. PubMed PMID: 21052488; PubMed Central PMCID: PMCPMC2967828.
  2. Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010;13:367-73. doi: 10.1111/j.1756-185X.2010.01549.x. PubMed PMID: 21199472.
  3. Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol. 2008;35:1384. PubMed PMID: 18464299.
  4. Canpolat O, Yurtsever S. The Quality of Life in Patients With Behcet’s Disease. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5:229-35. doi: 10.1016/j.anr.2011.12.003. PubMed PMID: 25030525.
  5. Ertam I, Kitapcioglu G, Aksu K, Keser G, Ozaksar A, Elbi H, et al. Quality of life and its relation with disease severity in Behcet’s disease. Clin Exp Rheumatol. 2009;27:S18-22. PubMed PMID: 19796527.
  6. Melikoglu M, Melikoglu MA. What affects the quality of life in patients with Behcet’s disease? Acta Reumatol Port. 2014;39:46-53. PubMed PMID: 24811461.
  7. Bernabe E, Marcenes W, Mather J, Phillips C, Fortune F. Impact of Behcet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford). 2010;49:2165-71. doi: 10.1093/rheumatology/keq251. PubMed PMID: 20675710.
  8. Uguz F, Dursun R, Kaya N, Cilli AS. Quality of life in patients with Behcet’s disease: the impact of major depression. Gen Hosp Psychiatry. 2007;29:21-4. doi: 10.1016/j.genhosppsych.2006.10.001. PubMed PMID: 17189740.
  9. Fabiani C, Vitale A, Orlando I, Sota J, Capozzoli M, Franceschini R, et al. Quality of life impairment in Behcet’s disease and relationship with disease activity: a prospective study. Intern Emerg Med. 2017;12:947-55. doi: 10.1007/s11739-017-1691-z. PubMed PMID: 28620840.
  10. Koca I, Savas E, Ozturk ZA, Tutoglu A, Boyaci A, Alkan S, et al. The relationship between disease activity and depression and sleep quality in Behcet’s disease patients. Clin Rheumatol. 2015;34:1259-63. doi: 10.1007/s10067-014-2632-0. PubMed PMID: 24816545.
  11. Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, et al. Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet’s disease. J Oral Pathol Med. 2009;38:406-9. doi: 10.1111/j.1600-0714.2009.00752.x. PubMed PMID: 19298505.
  12. Mumcu G, Hayran O, Ozalp DO, Inanc N, Yavuz S, Ergun T, et al. The assessment of oral health-related quality of life by factor analysis in patients with Behcet’s disease and recurrent aphthous stomatitis. J Oral Pathol Med. 2007;36:147-52. doi: 10.1111/j.1600-0714.2007.00514.x. PubMed PMID: 17305636.
  13. Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R. Arthropathy, quality of life, depression, and anxiety in Behcet’s disease: relationship between arthritis and these factors. Clin Rheumatol. 2006;25:524-31. doi: 10.1007/s10067-005-0100-6. PubMed PMID: 16639519.
  14. Onal S, Savar F, Akman M, Kazokoglu H. Vision- and health-related quality of life in patients with Behcet uveitis. Arch Ophthalmol. 2010;128:1265-71. doi: 10.1001/archophthalmol.2010.209. PubMed PMID: 20937995.
  15. Tanriverdi N, Taskintuna, Duru C, Ozdal P, Ortac S, Firat E. Health-related quality of life in Behcet patients with ocular involvement. Jpn J Ophthalmol. 2003;47:85-92. doi: 10.1016/s0021-5155(02)00647-0. PubMed PMID: 12586184.
  16. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behcet’s disease. J Rheumatol. 2004;31:931-7. PubMed PMID: 15124253.
  17. Vojdanian M, Faezi ST, Tennant A, Morgan AW, Paragomi P, Qorbani M, et al. Validity and reliability of the Persian version of Behcet’s disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation. Rheumatol Int. 2015;35:677-84. doi: 10.1007/s00296-014-3128-6. PubMed PMID: 25216713.
  18. Touma Z, Ghandour L, Sibai A, Puzantian H, Hamdan A, Hamdan O, et al. Cross-cultural adaptation and validation of Behcet’s disease quality of life questionnaire. BMC Med Res Methodol. 2011;11:52. doi: 10.1186/1471-2288-11-52. PubMed PMID: 21507231; PubMed Central PMCID: PMCPMC3111402.
  19. Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES. The Behcet’s Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J. 2008;49:698-704. doi: 10.3349/ymj.2008.49.5.698. PubMed PMID: 18972588; PubMed Central PMCID: PMCPMC2615362.
  20. International Team for the Revision of the International Criteria for Behcet’s D. The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338-47. doi: 10.1111/jdv.12107. PubMed PMID: 23441863.
  21. Organization WH. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version, December 1996. GenevaWorld Health Organization, 1996.
  22. Nejat S, Montazeri A, Holakouie Naieni K, Mohammad K, Majdzadeh S. The World Health Organization quality of Life (WHOQOL-BREF) questionnaire: Translation and validation study of the Iranian version. Journal of School of Public Health and Institute of Public Health Research. 2006;4:1-12.
  23. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38:728-33. doi: 10.1093/rheumatology/38.8.728. PubMed PMID: 10501420.
  24. Choi HJ, Seo MR, Ryu HJ, Baek HJ. Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea. Korean J Intern Med. 2016;31:170-5. doi: 10.3904/kjim.2016.31.1.170. PubMed PMID: 26767871; PubMed Central PMCID: PMCPMC4712422.
آمار
تعداد مشاهده مقاله: 3,338
تعداد دریافت فایل اصل مقاله: 2,848


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب